Medikinet® XL can be used as part of a comprehensive treatment programme for attention deficit hyperactivity disorder (ADHD) in children aged 6 years of age and over and adults when remedial measures alone aren’t sufficient. 1
Medikinet® XL consists of an immediate-release component (50% of dose) and a modified-release component (50% of dose). This is why Medikinet XL 10 mg yields an immediate-release dose of 5 mg and an extended-release dose of 5 mg. 1
The extended-release portion of each dose is designed to maintain a treatment response through the afternoon, without the need for a midday dose. This is designed to work with the school day, delivering therapeutic plasma levels for around 8 hours. 1
The extended-release portion of each dose is designed to maintain a treatment response into the afternoon. Because adults may have further responsibilities into the evening Medikinet XL should be taken twice a day, to maintain the therapeutic effect into the evening. 1
For full safety information please refer to section 4 of the SmPC or click here.
Adult patients who’ve shown clear benefit from treatment with Medikinet® XL in childhood or adolescence may continue treatment into adulthood. Initially, this can be at the same daily dose (mg/day). Whether an adjustment is needed depends on how well it continues to work and it's tolerability. 1
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare Professionals are asked to report any suspected adverse reactions.
EXTERNAL LINK
You are now leaving the Medice UK website and are being directed to a website that contains information about Medice products, but which is not owned by Medice UK.
Please confirm you wish to follow this link.